Viewing Study NCT00172341



Ignite Creation Date: 2024-05-05 @ 11:55 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00172341
Status: UNKNOWN
Last Update Posted: 2005-11-03
First Post: 2005-09-12

Brief Title: Sublingual Immunotherapy With House Dust Mite Extract in Asthmatic Children
Sponsor: National Taiwan University Hospital
Organization: National Taiwan University Hospital

Study Overview

Official Title: Efficacy and Safety of Sublingual Immunotherapy With House Dust Mite Extract in Asthmatic Children A Double-Blind Randomized and Placebo-Controlled Study
Status: UNKNOWN
Status Verified Date: 2004-07
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Asthma the airway inflammatory disorder is an important chronic disease in children About 1015 children are bothered with this Allergens such as house-dust mites HDM animal dander ie cats and dogs and seasonal pollens are often implicated as causative and triggering factors of respiratory attacks in children with asthma Among them mites are the most common indoor allergen associated with asthma worldwide

It appears that SLIT is somewhat effective and safe However on the current evidence further studies are needed to define the indications the duration of treatment and therapeutic optimal dose of standardized allergen extracts in relation to efficacy and side effects before it is recommended for routine clinical use The objective of the present study was to investigate the effects and safety of StaloralTM the standardized extracts of D pt and D f in asthmatic children allergic to HDM
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None